ALB and hepatocellular carcinoma: Briefly, the score ranged from 0 adding up to 3, according to whether or not the patient presents the following variables, all of which were found to be significant predictors of HCC development, according to the multivariate analysis: (a) a baseline LSM > 17.3 kPa, (b) a baseline serum albumin < 4.2 g/dL, and (c) a one-year follow-up after DAA treatment delta LSM < 25.5% (a decrease in LSM smaller than 25.5% compared to pre-therapy).